BioTelemetry (BioTelemetry) Cash-to-Debt : 0.55 (As of Sep. 2020)

BioTelemetry Cash-to-Debt Chart

BioTelemetry Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19
Cash-to-Debt		Get a 7-Day Free Trial					0.81	0.91	0.18	0.40	0.34

BioTelemetry Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Cash-to-Debt	Get a 7-Day Free Trial															0.31	0.34	0.46	0.51	0.55

Competitive Comparison of BioTelemetry's Cash-to-Debt

For the Diagnostics & Research subindustry, BioTelemetry's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioTelemetry's Cash-to-Debt Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BioTelemetry's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where BioTelemetry's Cash-to-Debt falls into.

BioTelemetry Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

BioTelemetry's Cash to Debt Ratio for the fiscal year that ended in Dec. 2019 is calculated as:

BioTelemetry's Cash to Debt Ratio for the quarter that ended in Sep. 2020 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioTelemetry  (NAS:BEAT) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

BioTelemetry Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of BioTelemetry's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BioTelemetry (BioTelemetry) Business Description